Renovascular hypertension and insulin sensitivity

Area of Science:

• Endocrinology
• Cardiovascular Physiology
• Metabolic Research

Background:

• The renin-angiotensin-aldosterone system (RAAS) plays a key role in blood pressure regulation and electrolyte balance.
• Its potential influence on insulin sensitivity and glucose metabolism is an area of ongoing investigation.
• Renovascular hypertension, caused by renal artery stenosis, activates the RAAS.

Purpose of the Study:

• To investigate whether the status of the renin-angiotensin-aldosterone system affects insulin sensitivity.
• To determine if renovascular hypertension is associated with insulin resistance.
• To assess the impact of ACE inhibition on insulin sensitivity and electrolyte metabolism in hypertensive patients.

Main Methods:

• Insulin sensitivity was measured using the euglycaemic insulin clamp technique in eight patients with renovascular hypertension and eight normotensive controls.
• Measurements were taken at baseline and after 7 days of ACE inhibition in the patient group.
• Forearm blood flow, glucose utilization, and electrolyte handling during insulin infusion were assessed.

Main Results:

• Patients with renovascular hypertension exhibited normal insulin sensitivity, comparable to normotensive controls.
• ACE inhibition significantly reduced blood pressure and peripheral vascular resistance, and suppressed plasma angiotensin II and aldosterone levels.
• Despite marked RAAS suppression, insulin sensitivity, forearm blood flow, and the antinatriuretic/antikaliuretic effects of insulin remained unchanged.

Conclusions:

• Renovascular hypertension is not associated with insulin resistance.
• Selective and significant reduction of RAAS activity does not alter insulin action on glucose metabolism.
• ACE inhibition does not affect insulin's action on electrolyte metabolism in this patient group.